Venture Beat -
27 Sep 2018 21:10
A single device that can perform a slew of tests on a prick of blood was the promise of Theranos, a diagnostics startup that was found to have misled investors about its tech’s capabilities and whose founders were recently charged with fraud by the Securities and Exchange Commission. But Sight Diagnostics is not Theranos. Sight […]
Share this Article